Raphael Pharmaceutical (RAPH) Operating Expenses (2020 - 2024)
Raphael Pharmaceutical (RAPH) posted Operating Expenses of $394000.0 for Q4 2024, up 23.51% sequentially from $319000.0 in Q3 2024, and up 632.43% YoY from $53793.4 in Q1 2024.
Raphael Pharmaceutical (RAPH) Operating Expenses (2020 - 2024) Analysis & Trends
Raphael Pharmaceutical has reported Operating Expenses for 5 years, with the latest figure at $394000.0 in Q4 2024.
- Quarterly Operating Expenses rose 632.43% year-over-year to $394000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $394000.0 (down 62.15% YoY) and the FY2025 annual result came in at $648000.0, down 12.79% from the prior year.
- Operating Expenses improved to $394000.0 in Q4 2024 per RAPH's latest filing, from $319000.0 in the prior quarter.
- Over five years, Operating Expenses peaked at $1.4 million in Q3 2022 and troughed at -$74000.0 in Q4 2023.
- A 5-year average of $471411.8 and a median of $394000.0 in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses plunged 106.7% in 2023, then surged 632.43% in 2024.
- Over 5 years, Operating Expenses stood at $227000.0 in 2020, then jumped by 152.86% to $574000.0 in 2021, then jumped by 92.33% to $1.1 million in 2022, then tumbled by 106.7% to -$74000.0 in 2023, then soared by 632.43% to $394000.0 in 2024.
- According to Business Quant data, Operating Expenses over the past three periods registered $394000.0, $319000.0, and $249000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | 199,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 394,000.00 |
| Sep 30, 2024 | 319,000.00 |
| Jun 30, 2024 | 249,000.00 |
| Mar 31, 2024 | 547,000.00 |
| Dec 31, 2023 | -74,000.00 |
| Sep 30, 2023 | 729,000.00 |
| Jun 30, 2023 | 419,000.00 |
| Mar 31, 2023 | 258,000.00 |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | 1.43 Mn |
| Jun 30, 2022 | 612,000.00 |
| Mar 31, 2022 | 175,000.00 |
| Dec 31, 2021 | 574,000.00 |
| Sep 30, 2021 | 418,000.00 |
| Jun 30, 2021 | 385,000.00 |
| Mar 31, 2021 | 252,000.00 |
| Dec 31, 2020 | 227,000.00 |